Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow – A proof of concept study
Caroline Holm Nørgaard(Nordsjællands Hospital), Martin Bøgsted(Chr. Hansen (Denmark)), Andrew J. Gentles(Stanford Medicine), Lasse Hjort Jakobsen(Aalborg University Hospital), Jennifer R. Brown(Dana-Farber Cancer Institute), Tarec Christoffer El‐Galaly(Aalborg University Hospital), Alexander Schmitz(Chr. Hansen (Denmark)), Hans Erik Johnsen(Herlev Hospital), Julie Støve Bødker(Chr. Hansen (Denmark)), Josephine L. Klitgaard(Dana-Farber Cancer Institute), Preben Johansen(Chr. Hansen (Denmark)), Karen Dybkær(Aalborg University Hospital), Tobias Herold(German Cancer Research Center), Karsten Spiekermann(German Cancer Research Center)
Cited by 14
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
|Cell|2018|2.4k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k